BIRC5 and cancer: Survivin expression is not a typical characteristic of normal differentiated tissues but is frequently overexpressed in several cancers, including MPM [21,23,24,25,26,27]; facilitating cancer progression by enabling tumour cells to bypass apoptotic checkpoints [21].